Pre-earnings options volume in Mineralys Therapeutics (MLYS) Inc is normal with calls leading puts 5:1. Implied volatility suggests the market is anticipating a move near 6.5%, or 0c, after results are released. Median move over the past eight quarters is 0.9%.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MLYS:
- MLYS Upcoming Earnings Report: What to Expect?
- Mineralys Reports Mixed Phase 2 Results for Lorundrostat
- Mineralys Therapeutics announces FDA acceptance of lorundrostat NDA
- Mineralys Therapeutics Inc options imply 20.5% move in share price post-earnings
- Mineralys Therapeutics Inc options imply 16.5% move in share price post-earnings